OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Replication Catastrophe: When a Checkpoint Fails because of Exhaustion
Luis Toledo, Kai J. Neelsen, Jiří Lukáš
Molecular Cell (2017) Vol. 66, Iss. 6, pp. 735-749
Open Access | Times Cited: 193
Luis Toledo, Kai J. Neelsen, Jiří Lukáš
Molecular Cell (2017) Vol. 66, Iss. 6, pp. 735-749
Open Access | Times Cited: 193
Showing 1-25 of 193 citing articles:
The molecular landscape of head and neck cancer
C. René Leemans, Peter J.F. Snijders, Ruud H. Brakenhoff
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 269-282
Closed Access | Times Cited: 1111
C. René Leemans, Peter J.F. Snijders, Ruud H. Brakenhoff
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 269-282
Closed Access | Times Cited: 1111
PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
Michael C. Lanz, Diego Dibitetto, Marcus B. Smolka
The EMBO Journal (2019) Vol. 38, Iss. 18
Open Access | Times Cited: 243
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 227
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 227
Hallmarks of DNA replication stress
Sneha Saxena, Lee Zou
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2298-2314
Open Access | Times Cited: 224
Sneha Saxena, Lee Zou
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2298-2314
Open Access | Times Cited: 224
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
Yong Fang, Daniel J. McGrail, Chaoyang Sun, et al.
Cancer Cell (2019) Vol. 35, Iss. 6, pp. 851-867.e7
Open Access | Times Cited: 197
Yong Fang, Daniel J. McGrail, Chaoyang Sun, et al.
Cancer Cell (2019) Vol. 35, Iss. 6, pp. 851-867.e7
Open Access | Times Cited: 197
HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA Synthesis
Gongshi Bai, Chames Kermi, Henriette Stoy, et al.
Molecular Cell (2020) Vol. 78, Iss. 6, pp. 1237-1251.e7
Open Access | Times Cited: 159
Gongshi Bai, Chames Kermi, Henriette Stoy, et al.
Molecular Cell (2020) Vol. 78, Iss. 6, pp. 1237-1251.e7
Open Access | Times Cited: 159
Phase separation properties of RPA combine high-affinity ssDNA binding with dynamic condensate functions at telomeres
Vincent Spegg, Ανδρέας Παναγόπουλος, Merula Stout, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 4, pp. 451-462
Open Access | Times Cited: 53
Vincent Spegg, Ανδρέας Παναγόπουλος, Merula Stout, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 4, pp. 451-462
Open Access | Times Cited: 53
Lesion Bypass and the Reactivation of Stalled Replication Forks
Kenneth J. Marians
Annual Review of Biochemistry (2018) Vol. 87, Iss. 1, pp. 217-238
Open Access | Times Cited: 158
Kenneth J. Marians
Annual Review of Biochemistry (2018) Vol. 87, Iss. 1, pp. 217-238
Open Access | Times Cited: 158
Targeting the replication stress response in cancer
Josep V. Forment, Mark J. O’Connor
Pharmacology & Therapeutics (2018) Vol. 188, pp. 155-167
Closed Access | Times Cited: 143
Josep V. Forment, Mark J. O’Connor
Pharmacology & Therapeutics (2018) Vol. 188, pp. 155-167
Closed Access | Times Cited: 143
Mitotic CDK Promotes Replisome Disassembly, Fork Breakage, and Complex DNA Rearrangements
Linhong Deng, R. Alex Wu, Romain Sonneville, et al.
Molecular Cell (2019) Vol. 73, Iss. 5, pp. 915-929.e6
Open Access | Times Cited: 131
Linhong Deng, R. Alex Wu, Romain Sonneville, et al.
Molecular Cell (2019) Vol. 73, Iss. 5, pp. 915-929.e6
Open Access | Times Cited: 131
The Initial Response of a Eukaryotic Replisome to DNA Damage
Martin R.G. Taylor, Joseph T.P. Yeeles
Molecular Cell (2018) Vol. 70, Iss. 6, pp. 1067-1080.e12
Open Access | Times Cited: 119
Martin R.G. Taylor, Joseph T.P. Yeeles
Molecular Cell (2018) Vol. 70, Iss. 6, pp. 1067-1080.e12
Open Access | Times Cited: 119
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors
Nisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 519-533.e8
Open Access | Times Cited: 106
Nisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 519-533.e8
Open Access | Times Cited: 106
Hydroxyurea—The Good, the Bad and the Ugly
Marcelina W. Musiałek, Dorota Rybaczek
Genes (2021) Vol. 12, Iss. 7, pp. 1096-1096
Open Access | Times Cited: 95
Marcelina W. Musiałek, Dorota Rybaczek
Genes (2021) Vol. 12, Iss. 7, pp. 1096-1096
Open Access | Times Cited: 95
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression
Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 8, pp. 1670-1682
Open Access | Times Cited: 91
Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 8, pp. 1670-1682
Open Access | Times Cited: 91
Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
Inge Ubink, Ana C.F. Bolhaqueiro, Sjoerd G. Elias, et al.
British journal of surgery (2019) Vol. 106, Iss. 10, pp. 1404-1414
Open Access | Times Cited: 88
Inge Ubink, Ana C.F. Bolhaqueiro, Sjoerd G. Elias, et al.
British journal of surgery (2019) Vol. 106, Iss. 10, pp. 1404-1414
Open Access | Times Cited: 88
Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
Lukáš Górecki, Martin Andrš, Martina Řezáčová, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107518-107518
Closed Access | Times Cited: 86
Lukáš Górecki, Martin Andrš, Martina Řezáčová, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107518-107518
Closed Access | Times Cited: 86
Reconstitution of translesion synthesis reveals a mechanism of eukaryotic DNA replication restart
Thomas A. Guilliam, Joseph T.P. Yeeles
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 5, pp. 450-460
Open Access | Times Cited: 80
Thomas A. Guilliam, Joseph T.P. Yeeles
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 5, pp. 450-460
Open Access | Times Cited: 80
Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
Lukáš Górecki, Martin Andrš, Jan Korábečný
Cancers (2021) Vol. 13, Iss. 4, pp. 795-795
Open Access | Times Cited: 78
Lukáš Górecki, Martin Andrš, Jan Korábečný
Cancers (2021) Vol. 13, Iss. 4, pp. 795-795
Open Access | Times Cited: 78
SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors
Ukhyun Jo, Yasuhisa Murai, Sirisha Chakka, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 6
Open Access | Times Cited: 58
Ukhyun Jo, Yasuhisa Murai, Sirisha Chakka, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 6
Open Access | Times Cited: 58
S1-END-seq reveals DNA secondary structures in human cells
Gabriel Matos‐Rodrigues, Niek van Wietmarschen, Wei Wu, et al.
Molecular Cell (2022) Vol. 82, Iss. 19, pp. 3538-3552.e5
Open Access | Times Cited: 40
Gabriel Matos‐Rodrigues, Niek van Wietmarschen, Wei Wu, et al.
Molecular Cell (2022) Vol. 82, Iss. 19, pp. 3538-3552.e5
Open Access | Times Cited: 40
Uniform Widespread Nuclear Phosphorylation of Histone H2AX Is an Indicator of Lethal DNA Replication Stress
Eric Moeglin, Dominique Desplancq, Sascha Conic, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 355-355
Open Access | Times Cited: 73
Eric Moeglin, Dominique Desplancq, Sascha Conic, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 355-355
Open Access | Times Cited: 73
Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer
Ethan Brill, Takuhei Yokoyama, Jayakumar R. Nair, et al.
Oncotarget (2017) Vol. 8, Iss. 67, pp. 111026-111040
Open Access | Times Cited: 72
Ethan Brill, Takuhei Yokoyama, Jayakumar R. Nair, et al.
Oncotarget (2017) Vol. 8, Iss. 67, pp. 111026-111040
Open Access | Times Cited: 72
Inherited DNA lesions determine G1 duration in the next cell cycle
Aleksandra Lezaja, Matthias Altmeyer
Cell Cycle (2017) Vol. 17, Iss. 1, pp. 24-32
Open Access | Times Cited: 71
Aleksandra Lezaja, Matthias Altmeyer
Cell Cycle (2017) Vol. 17, Iss. 1, pp. 24-32
Open Access | Times Cited: 71
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
Xiaolong Wei, Jiekun Yang, Sara J. Adair, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 45, pp. 28068-28079
Open Access | Times Cited: 67
Xiaolong Wei, Jiekun Yang, Sara J. Adair, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 45, pp. 28068-28079
Open Access | Times Cited: 67
